Cumberland Pharmaceuticals Reports First Quarter 2021 Financial Results & Company Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Cumberland Pharmaceuticals (CPIX) Tops Q1 EPS by 8c
May 11, 2021 4:11 PM EDTCumberland Pharmaceuticals (NASDAQ: CPIX) reported Q1 EPS of $0.01, $0.08 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $10.5 million versus the consensus estimate of $8.5 million.
At March 31, 2021, Cumberland had $93.3 million in total assets including $24.9 million in cash and cash equivalents. Total liabilities were... More
